Comparison
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874 vs 3 Hydroxydicarboxylic Aciduria C4024725
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Exogenous Maternal Derived Androgen and 3 Hydroxydicarboxylic Aciduria for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
A condition caused when a pregnant person takes hormone medications containing androgens, affecting fetal development. The fetus has XX chromosomes. Stopping the offending agent is key, with specialist care for affected infants.
3 Hydroxydicarboxylic Aciduria C4024725
A metabolic disorder affecting how the body processes certain fatty acids. Harmful acids can build up and may cause health issues. Treated with diet modifications and supportive care.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
Variable
3 Hydroxydicarboxylic Aciduria C4024725
0-10
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
severe
3 Hydroxydicarboxylic Aciduria C4024725
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
Chronic
3 Hydroxydicarboxylic Aciduria C4024725
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
No
3 Hydroxydicarboxylic Aciduria C4024725
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
reproductive
3 Hydroxydicarboxylic Aciduria C4024725
metabolic
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
endocrine
3 Hydroxydicarboxylic Aciduria C4024725
metabolic
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-exogenous-maternal-derived-androgen-C5679874 and 3-hydroxydicarboxylic-aciduria-C4024725 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874 | 3 Hydroxydicarboxylic Aciduria C4024725 | Discriminating power |
|---|---|---|---|
| Genital development | Atypical genital development may occur in a 46,XX fetus after maternal androgen exposure. | Genital atypicality is not described as a core feature. | High |
| Metabolic illness | Not characterized as fatty-acid acid accumulation. | Harmful acids may accumulate and cause health problems. | High |
| Age pattern | Onset is listed as variable and linked to prenatal exposure. | Onset is listed as childhood, ages 0–10. | Moderate |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874 when
Documented androgen-containing medication during pregnancy
The supplied cause is exogenous maternal androgen exposure.
High
46,XX infant with atypical genital findings
Chromosomal and reproductive features match the left concept.
Moderate
Need to stop an implicated exposure
Stopping the offending agent is stated as key, with specialist infant care.
Moderate
Choose 3 Hydroxydicarboxylic Aciduria C4024725 when
Suspected fatty-acid processing problem
The right concept is defined as a metabolic fatty-acid disorder.
High
Childhood presentation without sex-development history
Listed onset is 0–10 and the system is metabolic.
Moderate
Diet and supportive care are the stated approach
Management is described as dietary modification and support, not exposure cessation.
Moderate
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874 | 3 Hydroxydicarboxylic Aciduria C4024725 | Interpretation |
|---|---|---|---|
| Karyotype | 46,XX is part of the concept name. | No chromosomal pattern is supplied. | A karyotype supports classification only with clinical context; it does not diagnose the metabolic condition. |
| Exposure history | Maternal androgen-containing medication is the stated cause. | No medication exposure is required by the description. | History can suggest the left condition but does not prove causation. |
| Organic acid assessment | Not described as showing hydroxydicarboxylic acids. | The name denotes an aciduria finding, not by itself a complete diagnosis. | An abnormal result needs clinician and laboratory correlation; cutoffs are not supplied. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
- Outcome
- Listed as severe and chronic; individual outcome is not established.
- Factors
- Exposure cessation and specialist infant care are stated factors.
3 Hydroxydicarboxylic Aciduria C4024725
- Outcome
- Listed as moderate and chronic; individual outcome is not established.
- Factors
- Diet modification and supportive care are stated approaches.
Time frame: Left onset variable; right onset listed as ages 0–10. Lifelong course is not proven.
Severity labels differ, but mortality and exact prognosis are not supplied.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental effects | Fetal sex development may be affected; severity is listed as severe. Not described as a disorder of sex development. Exact complications are not established in the source. |
| Metabolic accumulation | Not described. Harmful acids may build up and cause health issues. Specific complications and rates are not provided. |
| Course | Listed as chronic despite stopping exposure. Listed as chronic and managed supportively. Long-term outcomes are not quantified. |
Patient education highlights
- HighDifferent causes
One follows prenatal androgen exposure in a 46,XX fetus; the other concerns fatty-acid metabolism.
- HighResults versus diagnosis
An abnormal genital finding or urine acid result is not automatically a final diagnosis.
- MediumCare pathway
Specialist review is appropriate. Do not start, stop, or change medicines or diet without a clinician.